<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>55267</identifier>
<setSpec>0539-6115</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Serafín, F</dc:author>
<dc:author>Gutiérrez, G</dc:author>
<dc:author>Sánchez, R</dc:author>
<dc:author>Ruiz-Gómez, J</dc:author>
<dc:author>Trucíos, G</dc:author>
<dc:author>Chena, M</dc:author>
<dc:description xml:lang="en">The usefulness of metisoprinol was evaluated by a double blind study and at random in the treatment of mild infectious hepatitis in a group of 42 children. Twenty-one patients were given the drug at the dose of 50 mg/kg/day, divided t.i.d., by mouth and for 12 days. The other twenty-one patients made up the control group and were given placebo. No modifications nor clinical differences were found in the parameters evaluated; laboratory results were also negative in the studies carried out that might be attributed to the administration of the drug.</dc:description>
<dc:type>Clinical Trial</dc:type>
<dc:language>es</dc:language>
<dc:date>1976 Jan-Feb </dc:date>
<dc:title xml:lang="es">Evaluación de metisoprinol+ en el tratamiento de la hepatitis infecciosa. Resultados negativos</dc:title>
<dc:title xml:lang="en">[Evaluation of methisoprinol+ in the treatment of infectious hepatitis. Negative results].</dc:title>
<dc:publisher>Boletin medico del Hospital Infantil de Mexico</dc:publisher>
</metadata>
</record>
</pubmed-document>
